Combine tissues into human-relevant systems.
From target validation to preclinical decisions, FluoSphera provides stage specific models built on the same technology, enabling coherent data across the drug discovery pipeline.
Microtissue B2S8
Microtissue B2S8
Microtissue B2S8
Microtissue B2S8
Available as an on-demand service or through licensing.
Find the right solution for your project stage.
feautres
FLUOSELECT
Compare drug response across 3D tissue systems for clearer efficacy and earlier go/no go decisions.
FLUOSCORE
Evaluate efficacy, safety, and liver driven effects in one integrated system for better dose & lead optimization decisions.
Pleiad
Investigate integrated drug response across tissues for omics and biomarker discovery.
Efficacy testing
Safety testing
DMPK-Tox
MoA / Biomarker discovery
Target identification/validation
Multi-tissue systems
Custom study design
Omics downstream
Standardizable
Duplicate to delete
Available as licence
On request
what fluoselect delivers
Not sure which service fits?
case studies
Seeing it work in practice.
All
Oncology
Liver + colon + breast
Irinotecan: liver-dependent efficacy, hepatotoxicity, and selectivity
All
Oncology
Liver + breast cancer
Tamoxifen: liver-dependent efficacy on breast adenocarcinoma
All
Oncology
6 cancer types
4-hydroxytamoxifen: selective efficacy on a 6-tissue co-culture
Future of Discovery
Predictive biology
starts today